96 related articles for article (PubMed ID: 18061835)
1. Unintended benefits of immunosupression on autoimmune disease due to chemoradiation therapy for head and neck cancer.
Syed MI; Clark LJ; Sturrock RD
Am J Otolaryngol; 2008; 29(1):63-5. PubMed ID: 18061835
[TBL] [Abstract][Full Text] [Related]
2. Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer.
Rengan R; Pfister DG; Lee NY; Kraus DH; Shah JP; Shaha AR; Ben-Porat LS; Zelefsky MJ
Am J Clin Oncol; 2008 Oct; 31(5):465-9. PubMed ID: 18838883
[TBL] [Abstract][Full Text] [Related]
3. Treatment of psoriasis with etanercept in a patient with a history of primary B-cell lymphoma.
Chong BF; Wong HK
Clin Exp Dermatol; 2009 Jul; 34(5):e11-3. PubMed ID: 19040508
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer.
Caudell JJ; Schaner PE; Meredith RF; Locher JL; Nabell LM; Carroll WR; Magnuson JS; Spencer SA; Bonner JA
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):410-5. PubMed ID: 18635320
[TBL] [Abstract][Full Text] [Related]
5. Success of prednisone in the treatment of a patient with sarcoidosis and systemic sclerosis: Report of a case.
Borges da Costa J; Mayer-da-Silva A; Soares de Almeida LM; Marques Gomes M
Dermatol Online J; 2009 Mar; 15(3):11. PubMed ID: 19379655
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
[TBL] [Abstract][Full Text] [Related]
7. Absence of planned neck dissection for the N2-N3 neck after chemoradiation for locally advanced squamous cell carcinoma of the head and neck.
Lau H; Phan T; Mackinnon J; Matthews TW
Arch Otolaryngol Head Neck Surg; 2008 Mar; 134(3):257-61. PubMed ID: 18347249
[TBL] [Abstract][Full Text] [Related]
8. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
[TBL] [Abstract][Full Text] [Related]
9. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
[TBL] [Abstract][Full Text] [Related]
10. Anemia during sequential induction chemotherapy and chemoradiation for head and neck cancer: the impact of blood transfusion on treatment outcome.
Bhide SA; Ahmed M; Rengarajan V; Powell C; Miah A; Newbold K; Nutting CM; Harrington KJ
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):391-8. PubMed ID: 18692326
[TBL] [Abstract][Full Text] [Related]
11. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
[TBL] [Abstract][Full Text] [Related]
12. Further experience of using azathioprine in the treatment of severe atopic dermatitis.
Hughes R; Collins P; Rogers S
Clin Exp Dermatol; 2008 Nov; 33(6):710-1. PubMed ID: 18681884
[TBL] [Abstract][Full Text] [Related]
13. Small cell carcinoma of the head and neck: the university of Miami experience.
Hatoum GF; Patton B; Takita C; Abdel-Wahab M; LaFave K; Weed D; Reis IM
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):477-81. PubMed ID: 19004574
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of carboplatin and paclitaxel for recurrent or metastatic head and neck cancer.
Ferrari D; Fiore J; CodecĂ C; Di Maria G; Bozzoni S; Bordin V; Caldiera S; Luciani A; Zonato S; Floriani I; Foa P
Anticancer Drugs; 2009 Mar; 20(3):185-90. PubMed ID: 19396017
[TBL] [Abstract][Full Text] [Related]
15. Report on immunosuppressive therapy.
Arch Immunol Ther Exp (Warsz); 1975; 23(2):161-76. PubMed ID: 1147741
[No Abstract] [Full Text] [Related]
16. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
[TBL] [Abstract][Full Text] [Related]
17. A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London Hospital: the first fifty patients.
Lu TY; Ng KP; Cambridge G; Leandro MJ; Edwards JC; Ehrenstein M; Isenberg DA
Arthritis Rheum; 2009 Apr; 61(4):482-7. PubMed ID: 19333973
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics, diagnostic criteria and therapeutic outcomes in autoimmune optic neuropathy.
Frohman L; Dellatorre K; Turbin R; Bielory L
Br J Ophthalmol; 2009 Dec; 93(12):1660-6. PubMed ID: 19692378
[TBL] [Abstract][Full Text] [Related]
19. Induction chemotherapy: to use or not to use? That is the question.
Brizel DM; Vokes EE
Semin Radiat Oncol; 2009 Jan; 19(1):11-6. PubMed ID: 19028340
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of patients with n3 neck nodes treated with chemoradiation.
Ballonoff A; Raben D; Rusthoven KE; Bassetti M; Kane M; Song JI; Chen C
Laryngoscope; 2008 Jun; 118(6):995-8. PubMed ID: 18364595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]